Diagnostic techniques and therapeutic challenges in patients with TP53 dysfunctional chronic lymphocytic leukemia

Leukemia & Lymphoma
Giles BestConstantine S Tam

Abstract

Abstract Aberrations of the TP53 pathway, whether by deletion or mutation, are increasingly recognized as one of the most important biological risk factors in chronic lymphocytic leukemia. Yet, there is little consensus on how to assess for TP53 defects in the clinic, and very few clinical studies to guide optimal management of such patients. In this review, we discuss the state-of-the-art in the assessment of the TP53 pathway, and review the evidence-base for therapeutic recommendations.

References

Sep 13, 1990·The New England Journal of Medicine·G JuliussonG Gahrton
May 1, 1993·Nature Genetics·D DittmerA J Levine
May 1, 1993·European Journal of Immunology·J GreenwoodH Waldmann
Dec 1, 2000·Nature·B VogelsteinA J Levine
Jan 3, 2001·The New England Journal of Medicine·H DöhnerP Lichter
Aug 9, 2002·The New England Journal of Medicine·Stephan Stilgenbauer, Hartmut Döhner
Jul 16, 2003·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·J ScheteligUNKNOWN Cooperative German Transplant Study Group
Apr 6, 2005·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Carol MorenoEmili Montserrat
Jun 21, 2006·The Journal of Immunology : Official Journal of the American Association of Immunologists·Jessica L TeelingJan G J van de Winkel
Nov 8, 2006·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Asher Chanan-KhanMyron S Czuczman
Nov 17, 2006·Leukemia·P DregerUNKNOWN Chronic Leukemia Working Party of the EBMT
Feb 7, 2007·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Michael R GreverJohn C Byrd
Feb 7, 2007·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Ian W FlinnMartin S Tallman
Feb 27, 2007·Bone Marrow Transplantation·I Ben-BassatR P Gale
Nov 7, 2007·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Peter HillmenJiri Mayer
Nov 9, 2007·Leukemia·T BromidgeD Howe
Aug 20, 2008·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Johannes ScheteligPeter Dreger
Jul 15, 2009·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Stephan StilgenbauerUNKNOWN German Chronic Lymphocytic Leukemia Study Group
Aug 26, 2009·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Francesc BoschEmili Montserrat
Oct 15, 2009·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Thomas S LinJohn C Byrd

❮ Previous
Next ❯

Related Concepts

Related Feeds

CNS Lymphoma

In CNS lymphoma, cancerous cells from lymph tissues or other parts of the body form tumors in the brain and/or spinal cord. Here is the latest research on this rare non-Hodgkin lymphoma.

B-Cell Leukemia (Keystone)

B-cell leukemia includes various types of lymphoid leukemia that affect B cells. Here is the latest research on B-cell leukemia.